IMPACT [gngm]
Apolipoprotein B/Apolipoprotein A-I [aapp]
Ratio [qnco]
Renal [bpoc]
Immunoglobulin A Nephropathy [dsyn]
Objective [inpr]
Apolipoprotein B/Apolipoprotein A-I [aapp]
Ratio [qnco]
Apo-B [aapp, bacs]
Apo A-I [aapp, bacs]
Patients [podg]
Cardiovascular disease [dsyn]
Study [mnob]
Evaluate [ftcn]
Raised [qnco]
Apo-B [aapp, bacs]
Apo A-I [aapp, bacs]
Values [qlco]
predictive [qlco]
Renal [bpoc]
Patients [podg]
Chronic kidney disease [dsyn]
Mechanisms [ftcn]
Atherosclerosis [dsyn]
Glomerulosclerosis [dsyn]
Patients [podg]
Immunoglobulin A Nephropathy [dsyn]
included [ftcn]
Represent [acty]
Homogeneous [qlco]
Group [idcn]
Patients [podg]
Chronic kidney disease [dsyn]
Material [sbst]
Methods [inpr]
Apo-B [aapp, bacs]
Apo A-I [aapp, bacs]
Serum Albumin [aapp]
Urine albumin [lbpr]
Blood Pressure [orgf]
Measured [qlco]
Highly sensitive [qlco]
c reactive protein test [lbpr]
carried [acty]
Out [spco]
Patients [podg]
Immunoglobulin A Nephropathy [dsyn]
Age [orga]
Gender [orga]
matched [resa]
HEALTHY SUBJECTS [popg]
Patients [podg]
Renal Disease, End-Stage [dsyn]
Defined [cnce]
Reaching [orgf]
Chronic kidney disease stage 5 [dsyn, fndg]
Estimated [qnco]
Glomerular Filtration Rate [diap]
mL/min [qnco]
M NOS [aapp, imft]
baseline [bodm]
Apo-B [aapp, bacs]
Apo A-I [aapp, bacs]
Values [qlco]
Men [popg]
Women [popg]
Chronic kidney disease stage 5 [dsyn, fndg]
Risk Ratio [qnco]
P NOS [aapp, imft]
baseline [bodm]
GFR [diap]
Serum Albumin [aapp]
Patients [podg]
Immunoglobulin A Nephropathy [dsyn]
Increased [qnco]
Apo-B [aapp, bacs]
Apo A-I [aapp, bacs]
Ratio [qnco]
High Risk [qlco]
Renal Disease, End-Stage [dsyn]
Compared [acty]
Patients [podg]
Ratio [qnco]
Controlled Study [resa]
interventions [hlca]
focusing [clna]
Apo-B [aapp, bacs]
Apo A-I [aapp, bacs]
Ratio [qnco]
effects [qlco]
